Stay updated with breaking news from Lynspad Alpha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Grifols (NASDAQ:GRFS – Get Free Report) was downgraded by investment analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “sell” rating in a report issued on Tuesday, Marketbeat Ratings reports. Separately, JPMorgan Chase & Co. increased their target price on Grifols from $10.00 to $10.50 and gave the company a “neutral” rating in […]
Tango Therapeutics (NASDAQ:TNGX – Get Free Report) and Grifols (NASDAQ:GRFS – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk. Profitability This table compares Tango Therapeutics and Grifols’ net […]
Grifols, S.A. (NASDAQ:GRFS – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $10.08, but opened at $10.54. Grifols shares last traded at $10.53, with a volume of 166,188 shares. Wall Street Analyst Weigh In Several equities research analysts recently commented on GRFS shares. Morgan Stanley […]
Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) have earned an average recommendation of “Hold” from the six ratings firms that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. GRFS has been the […]
StockNews.com began coverage on shares of Grifols (NASDAQ:GRFS – Free Report) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Morgan Stanley downgraded Grifols from an overweight rating to an equal weight rating in a research report on Tuesday, August 29th. Five […]